Altered Circadian Relationship Between Serum Nitric Oxide, Carbon Dioxide, and Uric Acid in Multiple Sclerosis

References

• Beckman J. S. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J. Developmental Physiol. 1991; 15: 53–59
   PubMedGoogle Scholar
• Bingham C., Arbogast B., Cornellisen G., Lee J. V., Halberg F. Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia 1982; 9: 397–439
   PubMedGoogle Scholar
• Copeman W. S. C. A short history of gout. The Genuine Works of Hippocrates Translated by Francis Adams, 1964. Berkeley University, California Press, New York 1883; Vol. I and II
   Google Scholar
• Cross A. H., Manning P. T., Stern M. K., Misko T. P. Evidence for the production of ONOO− in inflammatory CNS demyelination. J. Neuroimmunol. 1997; 80: 121–130, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cross A. H., Manning P. T., Keeling R. M., Schmidt R. E., Misko T. P. Peroxynitrite formation within the central nervous system in active multiple sclerosis. J. Neuroimmunol. 1998; 88: 45–56, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Davis J. W., Grandinetti A., Waslien C. I., Ross G. W., White L. R., Morens D. M. Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease. Am. J. Epidemiol. 1996; 144(5)480–484, [CSA]
   PubMed Web of Science ®Google Scholar
• Drulovic J., Dujmovic I., Stojsavljevic N., Mesaros S., Andjelkovic S., Miljkovic D., Peric V., Dragutovic G., Marinkovic J., Levic Z., Mostarica Stojkovic M. Uric acid levels in sera from patients with multiple sclerosis. J. Neurol. 2001; 248: 121–126, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fernandez J. R., Hermida R. C. Inferential statisti cal method for analysis of nonsinosoidal hybrid series with unequidistant observations. Chronobiol. Int. 1998; 15: 191–204, [CSA]
   PubMed Web of Science ®Google Scholar
• Fernandez J. R., Mojón A., Hermida R. C. Comparison of parameters from rhythmometric models with multiple components on hybrid data. Chronobiol. Int. 2004; 21(3)469–484, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Freal J. E., Kraft G. H., Coryell J. K. Symptomatic fatigue in multiple sclerosis. Arch. Phys. Med. Rehabil. 1984; 65: 135–138, [CSA]
   PubMed Web of Science ®Google Scholar
• Gucuyener K., Ergenekon E., Erbas D., Pinarli G., Serdaroglu. The serum nitric oxide levels in patients with Duchenne muscular dystrophy. Brain Development 2000; 22(3)181–183, [CROSSREF]
   PubMedGoogle Scholar
• Hermida R. C. Chronobiologic data analysis systems with emphasis in chronotherapeutic marker rhythmometry and chronoepidemiologic risk assessment. Chronobiotechnology and Chronobiological Engineering, L. E. Scheving, F. Halberg, C. F. Ehret. Martinus Nijhoff, Dordrecht 1987; pp. 88–119, NATO ASI series no 120
   Google Scholar
• Hooper D. C., Bagasra O., Marini J. C., Zborek A., Ohnishi S. R., Kean R., Champion J. M., Sarker A. B., Bobrowski L., Farber J. L., Akaike T., Maeda H., Koprowski H. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and ONOO−: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA. 1997; 94: 2528–2533, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hooper D. C., Spitsin S. V., Kean R. B., Champion J. M., Dickson G. M., Chaudhry I., Koprowski H. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Nat. Acad. Sci. USA 1998; 95: 675–680, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hooper D. C., Scott G. S., Zborek A., Mikheeva T., Kean R. B., Koprowski H., Spitsin S. V. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J. 2000; 14: 691–698, [CSA]
   PubMed Web of Science ®Google Scholar
• Hooper D. C., Kean R. B., Scott G. S., Spitsin S. V., Morimoto K., Bette M., Rohrenbeck A. M., Dietzschold B., Weihe E. The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J. Immunol. 2001; 167: 3470–3477
   PubMed Web of Science ®Google Scholar
• Kanabrocki E. L., Sothern R. B., Scheving L. E., Vesely D. L., Tsai T. H., Shelstad J., Cournoyer C., Greco J., Mermall H., Nemchausky B. M., Bushnell D. L., Kaplan E., Kahn S., Augustine G., Holmes E., Rumbyrt J., Sturtevant R. P., Sturtevant F., Bremmer F., Third J. L. H. C., McCormick J. B., Mudd C. A., Dawson S., Olwin J. H., Sackett-Lundeen L., Haus E., Halberg F., Pauly J. E., Hrushesky W. J. M. Circadian reference data for men in fifth decade of life. Prog. Clin. Biol. Res. 1990a; 341A: 771–781
   PubMedGoogle Scholar
• Kanabrocki E. L., Sothern R. B., Scheving L. E., Vesely D. L., Tsai T. H., Shelstad J., Cournoyer C., Greco J., Mermall H., Ferlin H., Nemchausky B. M., Bushnell D. L., Kaplan E., Kahn S., Augustine G., Holmes E., Rumbyrt J., Sturtevant R. P., Sturtevant F., Bremmer F., Third J. L. H. C., McCormick J. B., Dawson S., Sackett-Lundeen L., Haus E., Halberg F., Pauly J. E., Olwin J. H. Reference values for circadian rhythms of 98 variables in clinically healthy men in the fifth decade of life. Chronobiol. Int. 1990b; 7: 445–461
   PubMed Web of Science ®Google Scholar
• Kanabrocki E. L., McCormick J. B., Hermida R. C., Bremner W. F., Third J. L. H. C., Ryan M. D., Hoppenstaedt D. A., Fareed J., Nemchausky B. A., Shirazi P., Scheving L. E., Olwin J. H. Circadian interrelationship between serum uric acid and nitric oxide in adult male subjects. JAMA 2000; 283(17)2240–2241, [CROSSREF]
   PubMedGoogle Scholar
• Kastenbauer S., Pfister H. W. Protection against meningitis-associated central nervous system complications by uric acid. Med. Hypoth. 2002; 58: 431, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Kastenbauer S., Koedel U., Pfister H. W. Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis. J. Infect. Dis. 1999; 180: 1164–1170, [CROSSREF]
   PubMedGoogle Scholar
• Kean R. B., Spitsin S. V., Mikheeva T., Scott G. S., Hooper D. C. The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the CNS in experimental allergic encephalomyelitis through maintenance of blood-CNS barrier integrity. J. Immunol. 2000; 165: 6511–6518
   PubMed Web of Science ®Google Scholar
• Koprowski H., Spitsin S. V., Hooper D. C. Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Annals of Neurology 2001; 49: 139, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Liu J. S., Zhao M. L., Brosnan C. F., Lee S. C. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 2001; 158: 2057–2066
   PubMed Web of Science ®Google Scholar
• Longo-Mbenza B., Luila E. L., Mbete P., Vita E. K. Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans?. Int. J. Cardiol. 1999; 71: 17–22, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Maesaka J. K., Wolf-Klein G., Piccione J. M., Ma C. M. Hypouricemia, abnormal renal tubular urate transport, and plasma natriuretic factor(s) in patients with Alzheimer's disease. J. Am. Geriatr. Soc. 1993; 41: 501–506
   PubMedGoogle Scholar
• McLaren M., Kirk G., Bolton-Smith C., Belch J. J. Seasonal variation in plasma levels of endothelin-1 and nitric oxide. Intern. Angiol. 2000; 19(4)351–353
   PubMedGoogle Scholar
• Mojon A., Fernandez J. R., Hermida R. C. An interactive software package for chronobiologic time series analysis written for Macintosh computer. Chronbiol. Int. 1992; 9(6)403–412
   PubMed Web of Science ®Google Scholar
• Moncada S., Palmer R. M. J., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991; 43: 109–142
   PubMed Web of Science ®Google Scholar
• Morris M. E., Cantwell C., Vowels L., Dodd K. Changes in gait and fatigue from morning to afternoon in people with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2002; 72(3)361–365, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ochoa J. B., Udekwu A. O., Billiar T. R., Curran R. D., Cerra F. B., Simmons R. L., Peitzman A. B. Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 1991; 214: 621–626
   PubMed Web of Science ®Google Scholar
• Scott G. S., Hooper D. C. The role of uric acid in protecting the central nervous system from peroxynitrite-mediated pathology. Med. Hypoth. 2000; 56: 95–100, [CROSSREF], [CSA]
   Google Scholar
• Scott G. S., Spitsin S. V., Kean R. B., Mikheeva T., Koprowski H., Hooper D. C. Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc. Natl. Acad. Sci. USA 2002; 99(25)16303–16308, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Sotgiu S., Vanoli M., Pugliatti G., Fresu V., Agnetti I., Rostati A. G. Correlation between urate level and clinical course of multiple sclerosis. J. Neuroimmunol. 1999; A53
   Google Scholar
• Sothern R. B., Vesely D. L., Kanabrocki E. L., Bremner F. W., Third J. L. H. C., Boles M. A., Nemchausky B. M., Olwin J. H., Scheving L. E. Blood pressure and atrial natriuretic peptides correlate throughout the day. Am. Heart J. 1995a; 129: 907–916, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Sothern R. B., Vesely D. L., Kanabrocki E. L., Hermida R. C., Bremner F. W., Third J. L. H. C., Boles M. A., Nemchausky B. M., Olwin J. H., Scheving L. E. Temporal (circadian) and functional relationship between atrial natriuretic peptides and blood pressure. Chronobiol. Int. 1995b; 12: 106–120, [CSA]
   PubMed Web of Science ®Google Scholar
• Spitsin S. V., Scott G. S., Kean R. B., Mikheeva T., Hooper D. C. Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid. Neurosci. Lett. 2000; 292: 137–141, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Spitsin S., Hooper D. C., Mikheeva T., Koprowski H. Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins. Mult. Scler. 2001a; 7: 165–166, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Spitsin S., Hooper D. C., Leist T., Streletz L. J., Mikheeva T., Koprowskil H. Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease. Mult. Scler. 2001b; 7(5)313–319, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Squadrito G. L., Pryor W. A. The formation of ONOO− in vivo from nitric oxide and superoxide. Chemico-Biological Interactions 1995; 96: 203–206, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Squadrito S. L., Cueto R., Splenser A. E., Valavanidis A., Zhang H., Uppu R. M., Pryor W. A. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch. Biochem. Biophys. 2000; 376: 333–337, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sumimo H., Sato K., Sakamaki T., Kanda T., Nakamura T., Takahashi T., Sakamoto H., Kobayashi T., Nagai R. Reduced production of nitric oxide during haemodialysis. J. Hum. Hypertens. 1999; 13(7)437–422, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Taskiran D., Sagduyu A., Yuceyar N., Kutay F. Z., Pogun S. Increased cerebrospinal fluid and serum nitrite and nitrate levels in amyotrophic Lateral Sclerosis. Int. J. Neuroscience 2000; 101: 65–72, [CSA]
   PubMed Web of Science ®Google Scholar
• Teng R. J., Ye Y. Z., Parks D. A., Beckman J. S. Urate produced during hypoxia protects heart proteins from peroxynitrite-mediated protein nitration. Free Radical Biol. Med. 2002; 33: 1243–1249, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Toncev G., Milici B., Toncev S., Samardzic G. Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur. J. Neurol. 2002a; 9: 221–226, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Toncev G., Milicic B., Toncev S., Samardzic G. High-dose methylprednisolone therapy in multiple sclerosis increases serum uric acid levels. Clin. Chem. Lab. Med. 2002b; 40(5)505–508, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Touitou Y., Portaluppi F., Smolensky M. H., Rensing L. Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol. Int. 2004; 21(1)161–170, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• van der Veen R. C., Hinton D. R., Incardonna F., Hofman F. M. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J. Neuroimmunol. 1997; 77: 1–7, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Varela Eschavarria A., Montes de Oca-Luna R., Barrera-Saldana H. A. Uricase protein sequences: conserved during hominid evolution but absent in humans. FASEB J. 1988; 2: 3092–3096
   PubMedGoogle Scholar
• Yamamoto T., Katayamam I., Mishiokam K. Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J. Rheumatology 1998; 25(2)314–317
   PubMedGoogle Scholar